The Clinical Operations team at Silence Therapeutics Plc is responsible for overseeing the planning, execution, and management of clinical trials for RNA interference-based therapies. This team ensures compliance with regulatory standards, coordinates cross-functional collaboration, and drives the successful delivery of projects from conception through to regulatory approval, ultimately contributing to the advancement of innovative gene therapeutics.